Konstantinos Kelaidonis

669 total citations
19 papers, 215 citations indexed

About

Konstantinos Kelaidonis is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Konstantinos Kelaidonis has authored 19 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Computational Theory and Mathematics. Recurrent topics in Konstantinos Kelaidonis's work include Receptor Mechanisms and Signaling (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Computational Drug Discovery Methods (7 papers). Konstantinos Kelaidonis is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Computational Drug Discovery Methods (7 papers). Konstantinos Kelaidonis collaborates with scholars based in Greece, Canada and Australia. Konstantinos Kelaidonis's co-authors include John Matsoukas, Graham J. Moore, Vasso Apostolopoulos, Thomas Mavromoustakos, Anthony Zulli, Christos T. Chasapis, Harry Ridgway, Laura Kate Gadanec, Sotirios Tsiodras and Minos–Timotheos Matsoukas and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Amino Acids.

In The Last Decade

Konstantinos Kelaidonis

19 papers receiving 214 citations

Peers

Konstantinos Kelaidonis

CTM

CCM

James M. Schmidt United States

Line A. Ryberg Denmark

Damir Bojadzic United States

Stephen Noell United States

Abdullah A. Al‐Shammari Kuwait

Serap Beldar Canada

Xiaming Jiang China

Francine Liard Canada

Tobias John United Kingdom

J. Huyet France

James M. Schmidt United States

Konstantinos Kelaidonis

110 ×1.1

31 ×0.4

20 ×0.3

CTM

37 ×0.9

CCM

16 ×0.5

Citations per year, relative to Konstantinos Kelaidonis Konstantinos Kelaidonis (= 1×) peers James M. Schmidt

Countries citing papers authored by Konstantinos Kelaidonis

Since Specialization

Citations

This map shows the geographic impact of Konstantinos Kelaidonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantinos Kelaidonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantinos Kelaidonis more than expected).

Fields of papers citing papers by Konstantinos Kelaidonis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantinos Kelaidonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantinos Kelaidonis. The network helps show where Konstantinos Kelaidonis may publish in the future.

Co-authorship network of co-authors of Konstantinos Kelaidonis

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantinos Kelaidonis. A scholar is included among the top collaborators of Konstantinos Kelaidonis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantinos Kelaidonis. Konstantinos Kelaidonis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Moore, Graham J., Laura Kate Gadanec, Vasso Apostolopoulos, et al.. (2024). Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier. International Journal of Molecular Sciences. 25(11). 5779–5779. 4 indexed citations

Ridgway, Harry, Vasso Apostolopoulos, Graham J. Moore, et al.. (2024). Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses. Viruses. 16(11). 1776–1776. 3 indexed citations

Kelaidonis, Konstantinos, Massimiliano Peana, Sotirios Tsiodras, et al.. (2023). Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes. Proteomes. 11(2). 21–21. 1 indexed citations

Ridgway, Harry, Christos T. Chasapis, Konstantinos Kelaidonis, et al.. (2023). Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity. Viruses. 15(2). 309–309. 19 indexed citations

Kelaidonis, Konstantinos, Veroniki P. Vidali, Thomas Mavromoustakos, et al.. (2023). Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics. International Journal of Molecular Sciences. 24(9). 8454–8454. 9 indexed citations

Ridgway, Harry, John D. Orbell, Minos–Timotheos Matsoukas, et al.. (2023). W254 in furin functions as a molecular gate promoting anti-viral drug binding: Elucidation of putative drug tunneling and docking by non-equilibrium molecular dynamics. Computational and Structural Biotechnology Journal. 21. 4589–4612. 9 indexed citations

Gadanec, Laura Kate, Vasso Apostolopoulos, Graham J. Moore, et al.. (2023). Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019. Biomolecules. 13(5). 787–787. 16 indexed citations

Matsoukas, John, Laura Kate Gadanec, Anthony Zulli, et al.. (2022). Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2. Biomedicines. 10(7). 1731–1731. 8 indexed citations

Moore, Graham J., Harry Ridgway, Konstantinos Kelaidonis, et al.. (2022). Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System. Molecules. 27(15). 4854–4854. 10 indexed citations

10.

Ridgway, Harry, Christos T. Chasapis, Konstantinos Kelaidonis, et al.. (2022). Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy. Viruses. 14(5). 1029–1029. 26 indexed citations

11.

Ridgway, Harry, Graham J. Moore, Thomas Mavromoustakos, et al.. (2022). Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Computational and Structural Biotechnology Journal. 20. 2091–2111. 31 indexed citations

12.

Chasapis, Christos T., Konstantinos Kelaidonis, Harry Ridgway, Vasso Apostolopoulos, & John Matsoukas. (2022). The Human Myelin Proteome and Sub-Metalloproteome Interaction Map: Relevance to Myelin-Related Neurological Diseases. Brain Sciences. 12(4). 434–434. 2 indexed citations

13.

Matsoukas, John, et al.. (2021). Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan. Brain Sciences. 11(12). 1583–1583. 7 indexed citations

14.

Matsoukas, John, Vasso Apostolopoulos, Anthony Zulli, et al.. (2021). From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy. Molecules. 26(3). 618–618. 12 indexed citations

15.

Moore, Graham J., Konstantinos Kelaidonis, Laura Kate Gadanec, et al.. (2021). Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19. Biomolecules. 11(7). 979–979. 20 indexed citations

16.

Agelis, George, Konstantinos Kelaidonis, Dimitra Kalavrizioti, et al.. (2013). Facile and Efficient Syntheses of a Series of N-Benzyl and N-Biphenylmethyl Substituted Imidazole Derivatives Based on (E)-Urocanic acid, as Angiotensin II AT1 Receptor Blockers. Molecules. 18(7). 7510–7532. 7 indexed citations

17.

Agelis, George, Minos–Timotheos Matsoukas, Theodore Tselios, et al.. (2010). Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation. Amino Acids. 40(2). 411–420. 10 indexed citations

18.

Agelis, George, Serdar Durdağı, Konstantinos Kelaidonis, et al.. (2010). An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies. Journal of Computer-Aided Molecular Design. 24(9). 749–758. 20 indexed citations

19.

Tselios, Theodore, et al.. (2008). Solid Phase Synthesis of a Glycopeptide Analogue Using the Acid Sensitive 4-Methoxybenzhydryl Bromide Resin. Protein and Peptide Letters. 15(1). 1–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact